Similar Natural Products in NPASS
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC251559 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 7433 |
0.1-0.2 | 20936 |
0.2-0.3 | 1955 |
0.3-0.4 | 375 |
0.4-0.5 | 168 |
0.5-0.6 | 20 |
0.6-0.7 | 1 |
0.7-0.8 | 1 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
Similarity Score |
Similarity Level |
Natural Product ID |
0.7576 |
Intermediate Similarity |
NPC8576 |
0.6176 |
Remote Similarity |
NPC125872 |
0.5882 |
Remote Similarity |
NPC306277 |
0.5789 |
Remote Similarity |
NPC51659 |
0.561
|
Remote Similarity |
NPC324539 |
  Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC251559 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 281 |
0.1-0.2 | 7083 |
0.2-0.3 | 1378 |
0.3-0.4 | 311 |
0.4-0.5 | 90 |
0.5-0.6 | 11 |
0.6-0.7 | 5 |
0.7-0.8 | 2 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7576 |
Intermediate Similarity |
NPD9013 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD9012 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD9041 |
Approved |
0.6944 |
Remote Similarity |
NPD9039 |
Approved |
0.6944 |
Remote Similarity |
NPD9040 |
Clinical (unspecified phase) |
0.6286 |
Remote Similarity |
NPD8791 |
Clinical (unspecified phase) |
0.6087 |
Remote Similarity |
NPD9241 |
Approved |
0.575
|
Remote Similarity |
NPD8233 |
Phase 3 |